scholarly journals 06 / Prevalence of postoperative nausea and vomiting: the reality of our Ambulatory Surgery Unit – retrospective analysis

2018 ◽  
Author(s):  
Jânia Pacheco ◽  
João Galacho
Keyword(s):  
Retrospective Analysis ◽  
Postoperative Nausea ◽  
Ambulatory Surgery ◽  
Postoperative Nausea And Vomiting ◽  
Nausea And Vomiting

scholarly journals The efficacy of ginger added to ondansetron for preventing postoperative nausea and vomiting in ambulatory surgery

2014 ◽  
Vol 6 (1) ◽  
pp. 52 ◽  
Author(s):  
Anjan Das ◽  
Saikat Majumdar ◽  
Tapobrata Mitra ◽  
Ratul Kundu ◽  
Tapas Bhattacharyya ◽  
...  
Keyword(s):  
Postoperative Nausea ◽  
Ambulatory Surgery ◽  
Postoperative Nausea And Vomiting ◽  
Nausea And Vomiting

The Dose-Response Relationship of Ondansetron in Preventing Postoperative Emesis in Pediatric Patients Undergoing Ambulatory Surgery 

1995 ◽  
Vol 82 (1) ◽  
pp. 47-52 ◽  
Author(s):  
Mehernoor F. Watcha ◽  
Paul J. Bras ◽  
Gary D. Cieslak ◽  
John H. Pennant
Keyword(s):  
Postoperative Nausea ◽  
Ambulatory Surgery ◽  
Postoperative Nausea And Vomiting ◽  
Nausea And Vomiting ◽  
Controlled Study ◽  
Double Blind ◽  
Increased Risk ◽  
Effective Prophylaxis ◽  
Prophylaxis Of Emesis ◽  
Relationship Of

Background Postoperative nausea and vomiting is a distressing anesthetic complication that may delay discharge after ambulatory surgery. Effective prophylaxis for postoperative nausea and vomiting can be achieved in adults with lower doses of ondansetron, a 5-hydroxytryptamine subtype 3 receptor antagonist, compared with chemotherapy-induced emesis. However, the doses of ondansetron used in preventing postoperative nausea and vomiting in children are based on data from chemotherapy-induced emesis. The dose-related efficacy of intravenous ondansetron in the prophylaxis of postoperative emesis in the pediatric outpatient population was determined. Methods In a double-blind, randomized placebo-controlled study, 130 patients (mean age 5.7 +/- 3.4 yr) received placebo, 10, 50, or 100 micrograms/kg ondansetron during a standardized anesthetic. Episodes of postoperative vomiting or retching were recorded. Results Intravenous ondansetron in a dose of 50 micrograms/kg was more effective than placebo or a dose of 10 micrograms/kg in controlling the incidence and frequency of emesis in the hospital and during the first 24 postoperative hours. Increasing the dose of ondansetron to 100 micrograms/kg intravenously did not significantly reduce the incidence or frequency of emesis compared to 50 micrograms/kg intravenously. Conclusions Intravenous ondansetron in a dose of 50 micrograms/kg is as effective as larger doses for the prophylaxis of emesis in children undergoing surgical procedures known to be associated with an increased risk for postoperative nausea and vomiting.

Sign in / Sign up

Export Citation Format

Share Document